• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

速尿与精氨酸及P-糖蛋白抑制剂药物的共无定形制剂

Co-Amorphous Formulations of Furosemide with Arginine and P-Glycoprotein Inhibitor Drugs.

作者信息

Ruponen Marika, Kettunen Konsta, Santiago Pires Monica, Laitinen Riikka

机构信息

School of Pharmacy, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland.

Escola Superior de Tecnologia da Saúde de Lisboa, 1990-094 Lisbon, Portugal.

出版信息

Pharmaceutics. 2021 Jan 27;13(2):171. doi: 10.3390/pharmaceutics13020171.

DOI:10.3390/pharmaceutics13020171
PMID:33514009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7912042/
Abstract

In this study, the amino acid arginine (ARG) and P-glycoprotein (P-gp) inhibitors verapamil hydrochloride (VER), piperine (PIP) and quercetin (QRT) were used as co-formers for co-amorphous mixtures of a Biopharmaceutics classification system (BCS) class IV drug, furosemide (FUR). FUR mixtures with VER, PIP and QRT were prepared by solvent evaporation, and mixtures with ARG were prepared by spray drying in 1:1 and 1:2 molar ratios. The solid-state properties of the mixtures were characterized with X-ray powder diffraction (XRPD), Fourier-transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC) in stability studies under different storage conditions. Simultaneous dissolution/permeation studies were conducted in side-by-side diffusion cells with a PAMPA (parallel artificial membrane permeability assay) membrane as a permeation barrier. It was observed with XRPD that ARG, VER and PIP formed co-amorphous mixtures with FUR at both molar ratios. DSC and FTIR revealed single glass transition values for the mixtures (except for FUR:VER 1:2), with the formation of intermolecular interactions between the components, especially salt formation between FUR and ARG. The co-amorphous mixtures were found to be stable for at least two months under an elevated temperature/humidity, except FUR:ARG 1:2, which was sensitive to humidity. The dissolution/permeation studies showed that only the co-amorphous FUR:ARG mixtures were able to enhance both the dissolution and permeation of FUR. Thus, it is concluded that formulating co-amorphous salts with ARG may be a promising option for poorly soluble/permeable FUR.

摘要

在本研究中,氨基酸精氨酸(ARG)以及P-糖蛋白(P-gp)抑制剂盐酸维拉帕米(VER)、胡椒碱(PIP)和槲皮素(QRT)被用作生物药剂学分类系统(BCS)IV类药物呋塞米(FUR)共无定形混合物的共形成剂。通过溶剂蒸发法制备了FUR与VER、PIP和QRT的混合物,通过喷雾干燥法以1:1和1:2的摩尔比制备了FUR与ARG的混合物。在不同储存条件下的稳定性研究中,采用X射线粉末衍射(XRPD)、傅里叶变换红外光谱(FTIR)和差示扫描量热法(DSC)对混合物的固态性质进行了表征。在以PAMPA(平行人工膜通透性测定)膜作为渗透屏障的并排扩散池中进行了同步溶解/渗透研究。通过XRPD观察到,ARG、VER和PIP在两种摩尔比下均与FUR形成了共无定形混合物。DSC和FTIR显示混合物具有单一的玻璃化转变值(FUR:VER 1:2除外),各组分之间形成了分子间相互作用,特别是FUR与ARG之间形成了盐。发现共无定形混合物在高温/高湿条件下至少稳定两个月,但FUR:ARG 1:2对湿度敏感。溶解/渗透研究表明,只有共无定形的FUR:ARG混合物能够提高FUR的溶解和渗透能力。因此,得出结论,用ARG配制共无定形盐可能是提高难溶性/难渗透性FUR溶解度的一个有前景的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e663/7912042/29b9bb8bd25b/pharmaceutics-13-00171-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e663/7912042/ddf365c8a67b/pharmaceutics-13-00171-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e663/7912042/cebbe5037b02/pharmaceutics-13-00171-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e663/7912042/c4b7d47c344d/pharmaceutics-13-00171-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e663/7912042/d3ea37c630f9/pharmaceutics-13-00171-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e663/7912042/29b9bb8bd25b/pharmaceutics-13-00171-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e663/7912042/ddf365c8a67b/pharmaceutics-13-00171-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e663/7912042/cebbe5037b02/pharmaceutics-13-00171-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e663/7912042/c4b7d47c344d/pharmaceutics-13-00171-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e663/7912042/d3ea37c630f9/pharmaceutics-13-00171-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e663/7912042/29b9bb8bd25b/pharmaceutics-13-00171-g005.jpg

相似文献

1
Co-Amorphous Formulations of Furosemide with Arginine and P-Glycoprotein Inhibitor Drugs.速尿与精氨酸及P-糖蛋白抑制剂药物的共无定形制剂
Pharmaceutics. 2021 Jan 27;13(2):171. doi: 10.3390/pharmaceutics13020171.
2
Dissolution and Permeability Properties of Co-Amorphous Formulations of Hydrochlorothiazide.氢氯噻嗪共无定形制剂的溶出度和渗透性能。
J Pharm Sci. 2020 Jul;109(7):2252-2261. doi: 10.1016/j.xphs.2020.04.008. Epub 2020 Apr 18.
3
Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.喷雾干燥共无定形药物 - 氨基酸盐的制备与表征
J Pharm Pharmacol. 2016 May;68(5):615-24. doi: 10.1111/jphp.12458. Epub 2015 Aug 5.
4
Permeability of glibenclamide through a PAMPA membrane: The effect of co-amorphization.格列本脲经 PAMPA 膜的渗透:共无定形化的影响。
Eur J Pharm Biopharm. 2018 Aug;129:247-256. doi: 10.1016/j.ejpb.2018.06.007. Epub 2018 Jun 9.
5
Influence of variation in molar ratio on co-amorphous drug-amino acid systems.摩尔比对共无定形药物 - 氨基酸体系的影响。
Eur J Pharm Biopharm. 2016 Oct;107:32-9. doi: 10.1016/j.ejpb.2016.06.020. Epub 2016 Jun 28.
6
The effect of co-amorphization of glibenclamide on its dissolution properties and permeability through an MDCKII-MDR1 cell layer.格列本脲共无定形化对其溶解性能和通过 MDCKII-MDR1 细胞层的渗透性的影响。
Int J Pharm. 2019 Oct 30;570:118653. doi: 10.1016/j.ijpharm.2019.118653. Epub 2019 Aug 28.
7
Spray drying of poorly soluble drugs from aqueous arginine solution.从水溶液中精氨酸溶液喷雾干燥难溶性药物。
Int J Pharm. 2017 Oct 30;532(1):289-298. doi: 10.1016/j.ijpharm.2017.09.015. Epub 2017 Sep 8.
8
Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.制备无定形呋塞米钠盐可提高溶解度和溶出速率,并导致大鼠口服给药后的 Tmax 更快。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):942-51. doi: 10.1016/j.ejpb.2013.09.002. Epub 2013 Sep 27.
9
Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.氨基酸作为低水溶解性药物的共无定形稳定剂——第 1 部分:制备、稳定性和溶出度的提高。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):873-81. doi: 10.1016/j.ejpb.2013.03.014. Epub 2013 Mar 26.
10
Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.喷雾干燥法制备可吸入共无定形布地奈德-精氨酸干粉。
Int J Pharm. 2019 Jun 30;565:1-8. doi: 10.1016/j.ijpharm.2019.04.036. Epub 2019 Apr 15.

引用本文的文献

1
Cutting-Edge Approaches in the Co-Amorphization Process.共非晶化过程中的前沿方法。
Pharmaceutics. 2025 Jun 29;17(7):850. doi: 10.3390/pharmaceutics17070850.
2
The usefulness of infrared spectroscopy and X-ray powder diffraction in the analysis of falsified, illegal, and medicinal products.红外光谱法和X射线粉末衍射法在分析假药、非法药品和药用产品中的应用。
Front Chem. 2025 Feb 19;13:1536209. doi: 10.3389/fchem.2025.1536209. eCollection 2025.
3
Coformer-Dependent Physical Stability in a Series of Naringenin-Based Coamorphous Materials with Caffeine, Theophylline, and Theobromine.

本文引用的文献

1
Dissolution and Permeability Properties of Co-Amorphous Formulations of Hydrochlorothiazide.氢氯噻嗪共无定形制剂的溶出度和渗透性能。
J Pharm Sci. 2020 Jul;109(7):2252-2261. doi: 10.1016/j.xphs.2020.04.008. Epub 2020 Apr 18.
2
The effect of co-amorphization of glibenclamide on its dissolution properties and permeability through an MDCKII-MDR1 cell layer.格列本脲共无定形化对其溶解性能和通过 MDCKII-MDR1 细胞层的渗透性的影响。
Int J Pharm. 2019 Oct 30;570:118653. doi: 10.1016/j.ijpharm.2019.118653. Epub 2019 Aug 28.
3
High-Throughput Dissolution/Permeation Screening -A 96-Well Two-Compartment Microplate Approach.
基于柚皮素的共无定形物与咖啡因、茶碱和可可碱系列共晶物的构象依赖性物理稳定性。
Pharm Res. 2023 Dec;40(12):2847-2858. doi: 10.1007/s11095-023-03562-5. Epub 2023 Jul 28.
4
Data-Driven Prediction of the Formation of Co-Amorphous Systems.基于数据驱动的共无定形体系形成预测
Pharmaceutics. 2023 Jan 20;15(2):347. doi: 10.3390/pharmaceutics15020347.
5
A Review of Coformer Utilization in Multicomponent Crystal Formation.共晶物在多组分晶体形成中的应用综述。
Molecules. 2022 Dec 8;27(24):8693. doi: 10.3390/molecules27248693.
6
Amorphous and Co-Amorphous Olanzapine Stability in Formulations Intended for Wet Granulation and Pelletization.无定形和共无定形奥氮平在用于湿法制粒和制粒的制剂中的稳定性。
Int J Mol Sci. 2022 Sep 6;23(18):10234. doi: 10.3390/ijms231810234.
7
Downstream Processing of Amorphous and Co-Amorphous Olanzapine Powder Blends.非晶态和共非晶态奥氮平粉末混合物的下游处理
Pharmaceutics. 2022 Jul 23;14(8):1535. doi: 10.3390/pharmaceutics14081535.
8
Amorphization of Drugs for Transdermal Delivery-a Recent Update.用于透皮给药的药物非晶化——最新进展
Pharmaceutics. 2022 May 3;14(5):983. doi: 10.3390/pharmaceutics14050983.
高通量溶出/渗透筛选——一种96孔双室微孔板方法。
Pharmaceutics. 2019 May 10;11(5):227. doi: 10.3390/pharmaceutics11050227.
4
Involvement of metabolism-permeability in enhancing the oral bioavailability of curcumin in excipient-free solid dispersions co-formed with piperine.在无赋形剂固体分散体中与胡椒碱共同形成时,代谢-通透性的参与增强了姜黄素的口服生物利用度。
Int J Pharm. 2019 Apr 20;561:9-18. doi: 10.1016/j.ijpharm.2019.02.027. Epub 2019 Feb 25.
5
In situ co-amorphisation of arginine with indomethacin or furosemide during immersion in an acidic medium - A proof of concept study.在酸性介质中浸提时,通过共非晶化将精氨酸与吲哚美辛或呋塞米原位结合——概念验证研究。
Eur J Pharm Biopharm. 2018 Dec;133:151-160. doi: 10.1016/j.ejpb.2018.10.011. Epub 2018 Oct 16.
6
Preparation and characterization of multi-component tablets containing co-amorphous salts: Combining multimodal non-linear optical imaging with established analytical methods.多组份共无定形盐片的制备与特性研究:将多模态非线性光学成像与成熟的分析方法相结合。
Eur J Pharm Biopharm. 2018 Nov;132:112-126. doi: 10.1016/j.ejpb.2018.09.013. Epub 2018 Sep 22.
7
Permeability of glibenclamide through a PAMPA membrane: The effect of co-amorphization.格列本脲经 PAMPA 膜的渗透:共无定形化的影响。
Eur J Pharm Biopharm. 2018 Aug;129:247-256. doi: 10.1016/j.ejpb.2018.06.007. Epub 2018 Jun 9.
8
Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.在高湿度条件下联合储存时,吲哚美辛和精氨酸出现不理想的共无定形现象。
Int J Pharm. 2018 Jun 10;544(1):172-180. doi: 10.1016/j.ijpharm.2018.04.026. Epub 2018 Apr 15.
9
Characterization of systems with amino-acids and oligosaccharides as modifiers of biopharmaceutical properties of furosemide.以氨基酸和寡糖为修饰剂的呋塞米生物制药特性的系统表征。
J Pharm Biomed Anal. 2018 Feb 5;149:143-150. doi: 10.1016/j.jpba.2017.10.038. Epub 2017 Nov 2.
10
On the role of salt formation and structural similarity of co-formers in co-amorphous drug delivery systems.论共无定形药物递送系统中盐形成和共晶结构相似性的作用。
Int J Pharm. 2018 Jan 15;535(1-2):86-94. doi: 10.1016/j.ijpharm.2017.10.057. Epub 2017 Nov 2.